Following two previous successful biocide conferences, the 3rd Annual Prague Biocide Conference concentrates on the forthcoming challenges and experiences learnt from recent developments and what the future holds for the regulatory environment.
The conference is applicable for those involved in the biocides industry and is ideal for meeting representatives from a wide range of EU competent authorities as well as experts and industry participants from across Europe.
The event will again offer opportunities to gain an understanding and discuss the forthcoming challenges and experiences learnt from recent regulatory developments. It will focus on progress in active substance approvals and product authorisations as well as the expected workloads for industry with a special emphasis on SMEs.
Further topics will cover progress in efficacy test methods for disinfectants, progress made in comparative risk assessment within the renewal of anticoagulants, experience gained from handling first applications for antifouling products authorisations, granting authorisations through the simplified procedure and the same biocidal products authorisations.
It will also provide a detailed update on endocrine disruptors, additivity approach for reprotox health hazard for anticoagulants and further related expert areas, which will include a special session that will focus on country reports provided by representatives from competent authorities.
As with previous years, the conference will provide plenty of great opportunities for networking with fellow participants, include interactive discussions during Q&A and panel sessions and provide a great platform for service providers to showcase their services in a friendly and open environment.
It has previously attracted representatives from a wide range of EU competent authorities as well as experts in the biocides area and industry participants from across Europe and is sure to be yet another successful and informative event.
The conference is applicable for those involved in the biocides industry and is ideal for meeting representatives from a wide range of EU competent authorities as well as experts and industry participants from across Europe.
The event will again offer opportunities to gain an understanding and discuss the forthcoming challenges and experiences learnt from recent regulatory developments. It will focus on progress in active substance approvals and product authorisations as well as the expected workloads for industry with a special emphasis on SMEs.
Further topics will cover progress in efficacy test methods for disinfectants, progress made in comparative risk assessment within the renewal of anticoagulants, experience gained from handling first applications for antifouling products authorisations, granting authorisations through the simplified procedure and the same biocidal products authorisations.
It will also provide a detailed update on endocrine disruptors, additivity approach for reprotox health hazard for anticoagulants and further related expert areas, which will include a special session that will focus on country reports provided by representatives from competent authorities.
As with previous years, the conference will provide plenty of great opportunities for networking with fellow participants, include interactive discussions during Q&A and panel sessions and provide a great platform for service providers to showcase their services in a friendly and open environment.
It has previously attracted representatives from a wide range of EU competent authorities as well as experts in the biocides area and industry participants from across Europe and is sure to be yet another successful and informative event.
